XML 36 R26.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jul. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):

Three Months Ended July 31,Six Months Ended July 31,
2026202520262025
Cost of revenue
$
6,199 
$
5,399 
$
12,094 
$
10,064 
Research and development
28,401 
24,289 
57,349 
45,230 
Sales and marketing
21,472 
21,338 
41,757 
44,253 
General and administrative
25,221 
22,858 
44,982 
43,028 
Restructuring
10,821 
— 
10,821 
(36)
Total
$
92,114 
$
73,884 
$
167,003 
$
142,539 
Schedule of Restricted Stock Units
A summary of our RSU activity is as follows:

Number of RSUsWeighted-Average Grant Date Fair Value
Outstanding as of January 31, 2026
31,653,685 $18.99 
Granted
23,559,499 13.60 
Released(6,243,585)19.44 
Forfeited(5,751,782)17.50 
Outstanding as of July 31, 2026
43,217,817 $16.19 
Schedule of Performance Stock Units
A summary of our PSU activity is as follows:
Number of PSUsWeighted-Average Grant Date Fair Value
Outstanding as of January 31, 2026
1,246,801 $17.06 
Granted1,535,924 15.74 
Released(477,776)17.39 
Forfeited
(130,715)17.06 
Outstanding as of July 31, 2026
2,174,234 $16.06 
Schedule of Stock Options
A summary of our stock option activity is as follows:
Number of OptionsWeighted-Average Exercise Price
Outstanding as of January 31, 2026
9,443,196 $6.92 
Exercised(957,402)3.29 
Forfeited(17,252)1.64 
Outstanding as of July 31, 2026
8,468,542 $7.34 
Vested and expected to vest as of July 31, 2026
8,468,542 $7.34 
Vested and exercisable as of July 31, 2026
6,895,757 $7.14 
Schedule of Restricted Common Stock
Restricted common stock is included in issued and outstanding shares as they are legally issued and outstanding but are not deemed outstanding for accounting purposes until the shares vest. A summary of our restricted common stock activity is as follows:
Number of SharesWeighted-Average Grant Date Fair Value
Outstanding as of January 31, 2026
3,484,135 $20.60 
Vested
(1,120,114)23.82 
Unvested balance as of July 31, 2026
2,364,021 $19.07